Baerlocher, Gabriela M.

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006


Gilli, Stefanie; Novak, Urban; Mansouri Taleghani, Behrouz; Baerlocher, Gabriela M.; Leibundgut, Kurt; Banz Wälti, Yara; Zander, Thilo; Betticher, Daniel; Egger, Thomas; Rauch, Daniel; Pabst, Thomas (2017). BeEAM conditioning with bendamustine-replacing BCNU before autologous transplantation is safe and effective in lymphoma patients. Annals of hematology, 96(3), pp. 421-429. Springer 10.1007/s00277-016-2900-y


Heini, Alexander D; Berger, Martin Dave; Seipel, Katja; Mansouri Taleghani, Behrouz; Baerlocher, Gabriela M.; Leibundgut, Kurt; Banz, Yara; Novak, Urban; Pabst, Thomas (2016). Consolidation with autologous stem cell transplantation in first remission is safe and effective in AML patients above 65 years. Leukemia research, 53, pp. 28-34. Elsevier 10.1016/j.leukres.2016.12.001

Stettler, Jasmin; Novak, Urban; Baerlocher, Gabriela M.; Seipel, Katja; Mansouri Taleghani, Behrouz; Pabst, Thomas (2016). Autologous stem cell transplantation in elderly patients with multiple myeloma: evaluation of its safety and efficacy. Leukemia & lymphoma, 58(5), pp. 1076-1083. Informa Healthcare 10.1080/10428194.2016.1233542

Sellmann, Ludger; Scholtysik, Rene; de Beer, Dirk; Eisele, Lewin; Klein-Hitpass, Ludger; Nückel, Holger; Dührsen, Ulrich; Dürig, Jan; Röth, Alexander; Baerlocher, Gabriela M. (2016). Shorter telomeres correlate with an increase in the number of uniparental disomies in patients with chronic lymphocytic leukemia. Leukemia & lymphoma, 57(3), pp. 590-595. Informa Healthcare 10.3109/10428194.2015.1076929

Wagner, Anna Margareta; Krenger, Werner; Stettler, Shamsiya; Beutler, Elke; Herbst, Judith; Surbek, Daniel; Baerlocher, Gabriela M. (2016). A novel, bedside technique to rapidly identify umbilical cord blood units with high total nucleated cell numbers. Transfusion, 56(6), pp. 1406-1412. Wiley-Blackwell 10.1111/trf.13610

Miranda, M B; Lauseker, M; Kraus, M-P; Proetel, U; Hanfstein, B; Fabarius, A; Baerlocher, Gabriela M.; Heim, D; Hossfeld, D K; Kolb, H-J; Krause, S W; Nerl, C; Brümmendorf, T H; Verbeek, W; Fauser, A A; Prümmer, O; Neben, K; Hess, U; Mahlberg, R; Plöger, C; ... (2016). Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV. Leukemia, 30(6), pp. 1255-1262. Nature Publishing Group 10.1038/leu.2016.20

Gratwohl, A; Pfirrmann, M; Zander, A; Kröger, N; Beelen, D; Novotny, J; Nerl, C; Scheid, C; Spiekermann, K; Mayer, J; Sayer, H G; Falge, C; Bunjes, D; Döhner, H; Ganser, A; Schmidt-Wolf, I; Schwerdtfeger, R; Baurmann, H; Kuse, R; Schmitz, N; ... (2016). Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment. Leukemia, 30(3), pp. 562-569. Nature Publishing Group 10.1038/leu.2015.281


Baerlocher, Gabriela M.; Burington, Bart; Snyder, David S (2015). Telomerase Inhibitor Imetelstat in Essential Thrombocythemia and Myelofibrosis. The New England journal of medicine, 373(26), p. 2580. Massachusetts Medical Society 10.1056/NEJMc1512663

Baerlocher, Gabriela M.; Oppliger Leibundgut, Elisabeth; Ottmann, Oliver G; Spitzer, Gary; Odenike, Olatoyosi; McDevitt, Michael A; Röth, Alexander; Daskalakis, Michael; Burington, Bart; Stuart, Monic; Snyder, David S (2015). Telomerase Inhibitor Imetelstat in Patients with Essential Thrombocythemia. The New England journal of medicine, 373(10), pp. 920-928. Massachusetts Medical Society 10.1056/NEJMoa1503479

Riether, Carsten; Schürch, Christian; Flury, Christoph; Hinterbrandner, Magdalena; Drück, Linda; Huguenin, Anne-Laure; Baerlocher, Gabriela M.; Radpour, Ramin; Ochsenbein, Adrian (2015). Tyrosine kinase inhibitor-induced CD70 expression mediates drug resistance in leukemia stem cells by activating Wnt signaling. Science translational medicine, 7(298), 298ra119. American Association for the Advancement of Science 10.1126/scitranslmed.aab1740

Mager, Lukas; Riether, Carsten; Schürch, Christian; Banz Wälti, Yara; Wasmer, Marie-Hélène Christin; Stuber Roos, Regula; Theocharides, Alexandre; Li, Xiaohong; Xia, Yu; Saito, Hirohisa; Nakae, Susumu; Baerlocher, Gabriela M.; Manz, Markus G; McCoy, Kathleen; Macpherson, Andrew; Macpherson, Andrew; Ochsenbein, Adrian; Beutler, Bruce; Krebs, Philippe (2015). IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms. Journal of clinical investigation, 125(7), pp. 2579-2591. American Society for Clinical Investigation 10.1172/JCI77347

Haaß, Wiltrud; Kleiner, Helga; Weiß, Christel; Haferlach, Claudia; Schlegelberger, Brigitte; Müller, Martin C; Hehlmann, Rüdiger; Hofmann, Wolf-Karsten; Fabarius, Alice; Seifarth, Wolfgang; Baerlocher, Gabriela M.; Lämmle, Bernhard; Tobler, Andreas (2015). Clonal Evolution and Blast Crisis Correlate with Enhanced Proteolytic Activity of Separase in BCR-ABL b3a2 Fusion Type CML under Imatinib Therapy. PLoS ONE, 10(6), e0129648. Public Library of Science 10.1371/journal.pone.0129648

de Beer, Dirk; Völzmann, Jan; Kalka, Christoph; Baerlocher, Gabriela M. (2015). Longitudinal Telomere Erosion in Lymphocyte Subsets of Patients with Atherosclerotic Peripheral Arterial Disease (PAD). Journal of clinical and diagnostic research : JCDR, 9(3), OM01-OM03. Premchand Shantidevi Research Foundation 10.7860/JCDR/2015/10931.5684

Mathivanan, Isai; Trepp, Carolyn Mary; Brunold, Claudio; Baerlocher, Gabriela M.; Enzmann, Volker (2015). Retinal differentiation of human bone marrow-derived stem cells by co-culture with retinal pigment epithelium in vitro. Experimental cell research, 333(1), pp. 11-20. Elsevier 10.1016/j.yexcr.2015.02.001

Wetzel, Dana; Müller, Beatrice Ursula; Mansouri Taleghani, Behrouz; Baerlocher, Gabriela M.; Seipel, Katja; Leibundgut, Kurt; Pabst, Thomas (2015). Delayed Haematological recovery after autologous stem cell transplantation is associated with favourable outcome in acute myeloid leukaemia. British journal of haematology, 168(2), pp. 268-273. Wiley-Blackwell 10.1111/bjh.13118


Gotta, V; Widmer, N; Decosterd, L A; Chalandon, Y; Heim, D; Gregor, M; Benz, R; Leoncini-Franscini, L; Baerlocher, Gabriela M.; Duchosal, M A; Csajka, C; Buclin, T (2014). Clinical usefulness of therapeutic concentration monitoring for imatinib dosage individualization: results from a randomized controlled trial. Cancer chemotherapy and pharmacology, 74(6), pp. 1307-1319. Springer 10.1007/s00280-014-2599-1

Hanfstein, B; Shlyakhto, V; Lauseker, M; Hehlmann, R; Saussele, S; Dietz, C; Erben, P; Fabarius, A; Proetel, U; Schnittger, S; Krause, S W; Schubert, J; Einsele, H; Hänel, M; Dengler, J; Falge, C; Kanz, L; Neubauer, A; Kneba, M; Stegelmann, F; ... (2014). Velocity of early BCR-ABL transcript elimination as an optimized predictor of outcome in chronic myeloid leukemia (CML) patients in chronic phase on treatment with imatinib. Leukemia, 28(10), pp. 1988-1992. Nature Publishing Group 10.1038/leu.2014.153

Hanfstein, Benjamin; Lauseker, Michael; Hehlmann, Rüdiger; Saussele, Susanne; Erben, Philipp; Dietz, Christian; Fabarius, Alice; Proetel, Ulrike; Schnittger, Susanne; Haferlach, Claudia; Krause, Stefan W; Schubert, Jörg; Einsele, Hermann; Hänel, Mathias; Dengler, Jolanta; Falge, Christiane; Kanz, Lothar; Neubauer, Andreas; Kneba, Michael; Stegelmann, Frank; ... (2014). Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib. Haematologica - the hematology journal, 99(9), pp. 1441-1447. Ferrata-Storti Foundation 10.3324/haematol.2013.096537

Schmid, Andrea; Friess, Dorothea; Mansouri Taleghani, Behrouz; Keller, Peter; Müller, Beatrice Ursula; Baerlocher, Gabriela M.; Leibundgut, Kurt; Pabst, Thomas (2014). Role of plerixafor in autologous stem cell mobilization with vinorelbine chemotherapy and granulocyte-colony stimulating factor in patients with myeloma: a phase II study (PAV-trial). Leukemia & lymphoma, 56(3), pp. 608-614. Informa Healthcare 10.3109/10428194.2014.927454

Proetel, Ulrike; Pletsch, Nadine; Lauseker, Michael; Müller, Martin C; Hanfstein, Benjamin; Krause, Stefan W; Kalmanti, Lida; Schreiber, Annette; Heim, Dominik; Baerlocher, Gabriela M.; Hofmann, Wolf-Karsten; Lange, Elisabeth; Einsele, Hermann; Wernli, Martin; Kremers, Stephan; Schlag, Rudolf; Müller, Lothar; Hänel, Mathias; Link, Hartmut; Hertenstein, Bernd; ... (2014). Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV. Annals of hematology, 93(7), pp. 1167-1176. Springer 10.1007/s00277-014-2041-0

Hehlmann, Rüdiger; Müller, Martin C; Lauseker, Michael; Hanfstein, Benjamin; Fabarius, Alice; Schreiber, Annette; Proetel, Ulrike; Pletsch, Nadine; Pfirrmann, Markus; Haferlach, Claudia; Schnittger, Susanne; Einsele, Hermann; Dengler, Jolanta; Falge, Christiane; Kanz, Lothar; Neubauer, Andreas; Kneba, Michael; Stegelmann, Frank; Pfreundschuh, Michael; Waller, Cornelius F; ... (2014). Deep molecular response is reached by the majority of patients treated with imatinib, predicts survival, and is achieved more quickly by optimized high-dose imatinib: results from the randomized CML-study IV. Journal of clinical oncology, 32(5), pp. 415-423. American Society of Clinical Oncology 10.1200/JCO.2013.49.9020

de Wreede, Liesbeth C; Watson, Maggie; van Os, Marleen; Milligan, Donald; van Gelder, Michel; Michallet, Mauricette; Dreger, Peter; Dearden, Claire E; Homewood, Janis; Dupuis, Jehan; Leporrier, Michel; Karas, Michal; Corront, Bernadette; Baerlocher, Gabriela M.; Herr, Wolfgang; Choquet, Sylvain; Niederwieser, Dietger W; Sutton, Laurent; Kröger, Nicolaus; de Witte, Theo M; ... (2014). Improved relapse-free survival after autologous stem cell transplantation does not translate into better quality of life in chronic lymphocytic leukemia: lessons from the randomized European Society for Blood and Marrow Transplantation-Intergroup study. American journal of hematology, 89(2), pp. 174-180. Wiley-Liss 10.1002/ajh.23610

Jandus, Camilla; Frias Boligan, Kayluz; Chijioke, Obinna; Liu, He; Dahlhaus, Meike; Demoulins, Thomas; Schneider, Christoph; Wehrli, Marc; Hunger, Robert E.; Baerlocher, Gabriela M.; Simon, Hans-Uwe; Romero, Pedro; Münz, Christian; von Gunten, Stephan (2014). Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance. Journal of clinical investigation, 124(4), pp. 1810-1820. American Society for Clinical Investigation 10.1172/JCI65899


Oppliger Leibundgut, Elisabeth; Porret, Naomi A.; Abbal, Claire; Darbellay, Régis; Goede, Jeroen S.; Kalberer, Christian; Lehmann, Thomas; Baerlocher, Gabriela M. (2013). Molekulares BCR-ABL1-Monitoring bei CML gemäss neuen ELN-Empfehlungen. Internationale Skala in der Schweiz etabliert. Leading opinions - Hämatologie und Onkologie, 4(13), pp. 42-45. Universimed

Labarinas, Sonia; Gumy-Pause, Fabienne; Rougemont, Anne-Laure; Baerlocher, Gabriela; Leibundgut, Elisabeth O.; Porret, Naomi; Schäppi, Michela G.; Barazzone-Argiroffo, Constance; Passweg, Jakob; Merlini, Laura; Ozsahin, Hulya; Ansari, Marc (2013). Is Acute Fibrinous and Organizing Pneumonia the Expression of Immune Dysregulation? Journal of pediatric hematology, oncology, 35(2), pp. 139-143. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/MPH.0b013e31827e5782

Oppliger Leibundgut, Elisabeth; Porret, Naomi A.; Bienz Muggli, Marianne; Baumgartner, Heidi; Dahlhaus, Meike; Baerlocher, Gabriela M. (2013). Rapid and highly specific screening for NPM1 mutations in acute myeloid leukemia. Annals of hematology, 92(2), pp. 173-177. Berlin: Springer 10.1007/s00277-012-1617-9

Oppliger Leibundgut, Elisabeth; Baerlocher, Gabriela M. (2013). Molekulare Diagnostik: der Schlüssel zur zielgerichteten Therapie. Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS, 13(1), pp. 8-10. EMH Editores Medicorum Helveticorum


Oppliger Leibundgut, Elisabeth; Rogenmoser-Dissler, Daniela; de Beer, Dirk; Porret, Naomi A; Zibellini, Silvia; Dürig, Jan; Röth, Alexander; Klingbiel, Dirk; Baerlocher, Gabriela M (2012). CLLU1 expression distinguishes chronic lymphocytic leukemia from other mature B-cell neoplasms. Leukemia research, 36(9), pp. 1204-7. Amsterdam: Elsevier 10.1016/j.leukres.2012.05.015

Aubert, Geraldine; Baerlocher, Gabriela M.; Vulto, Irma; Poon, Steven S.; Lansdorp, Peter M. (2012). Collapse of telomere homeostasis in hematopoietic cells caused by heterozygous mutations in telomerase genes. PLoS genetics, 8(5), e1002696. San Francisco, Calif.: Public Library of Science 10.1371/journal.pgen.1002696

Hanfstein, B; Müller, M C; Hehlmann, R; Erben, P; Lauseker, M; Fabarius, A; Schnittger, S; Haferlach, C; Göhring, G; Proetel, U; Kolb, H-J; Krause, S W; Hofmann, W-K; Schubert, J; Einsele, H; Dengler, J; Hänel, M; Falge, C; Kanz, L; Neubauer, A; ... (2012). Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML). Leukemia, 26(9), pp. 2096-102. Basingstoke: Nature Publishing Group 10.1038/leu.2012.85

Anderson, Beverley H; Kasher, Paul R; Mayer, Josephine; Szynkiewicz, Marcin; Jenkinson, Emma M; Bhaskar, Sanjeev S; Urquhart, Jill E; Daly, Sarah B; Dickerson, Jonathan E; O'Sullivan, James; Leibundgut, Elisabeth Oppliger; Muter, Joanne; Abdel-Salem, Ghada M H; Babul-Hirji, Riyana; Baxter, Peter; Berger, Andrea; Bonafé, Luisa; Brunstom-Hernandez, Janice E; Buckard, Johannes A; Chitayat, David; ... (2012). Mutations in CTC1, encoding conserved telomere maintenance component 1, cause Coats plus. Nature genetics, 44(3), pp. 338-42. New York, N.Y.: Nature America 10.1038/ng.1084

Alter, Blanche P; Rosenberg, Philip S; Giri, Neelam; Baerlocher, Gabriela M; Lansdorp, Peter M; Savage, Sharon A (2012). Telomere length is associated with disease severity and declines with age in dyskeratosis congenita. Haematologica - the hematology journal, 97(3), pp. 353-9. Pavia: Ferrata-Storti Foundation 10.3324/haematol.2011.055269


Sellmann, Ludger; de Beer, Dirk; Bartels, Marius; Opalka, Bertram; Nückel, Holger; Dührsen, Ulrich; Dürig, Jan; Seifert, Marc; Siemer, Dörte; Küppers, Ralf; Baerlocher, Gabriela M; Röth, Alexander (2011). Telomeres and prognosis in patients with chronic lymphocytic leukaemia. International journal of hematology, 93(1), pp. 74-82. Tokyo: Springer 10.1007/s12185-010-0750-2

Humbert, Magali; Halter, Veronika; Shan, Deborah; Laedrach, Judith; Leibundgut, Elisabeth Oppliger; Baerlocher, Gabriela M; Tobler, Andreas; Fey, Martin F; Tschan, Mario P (2011). Deregulated expression of Kruppel-like factors in acute myeloid leukemia. Leukemia research, 35(7), pp. 909-13. Amsterdam: Elsevier 10.1016/j.leukres.2011.03.010

Fabarius, Alice; Leitner, Armin; Hochhaus, Andreas; Müller, Martin C; Hanfstein, Benjamin; Haferlach, Claudia; Göhring, Gudrun; Schlegelberger, Brigitte; Jotterand, Martine; Reiter, Andreas; Jung-Munkwitz, Susanne; Proetel, Ulrike; Schwaab, Juliana; Hofmann, Wolf-Karsten; Schubert, Jörg; Einsele, Hermann; Ho, Anthony D; Falge, Christiane; Kanz, Lothar; Neubauer, Andreas; ... (2011). Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV. Blood, 118(26), pp. 6760-8. Washington, D.C.: American Society of Hematology 10.1182/blood-2011-08-373902


Tschan, Mario P; Shan, Deborah; Laedrach, Judith; Eyholzer, Marianne; Leibundgut, Elisabeth Oppliger; Baerlocher, Gabriela M; Tobler, Andreas; Stroka, Deborah; Fey, Martin F (2010). NDRG1/2 expression is inhibited in primary acute myeloid leukemia. Leukemia research, 34(3), pp. 393-8. Amsterdam: Elsevier 10.1016/j.leukres.2009.08.037

Baerlocher, Gabriela M; Oppliger Leibundgut, Elisabeth (2010). [Molecular analyses for (early) recognition of hematologic diseases - sense and sensibility for molecular analysis: the art of intelligent decision-making]. Therapeutische Umschau, 67(7), pp. 349-58. Bern: Huber

Röth, Alexander; Harley, Calvin B; Baerlocher, Gabriela M (2010). Imetelstat (GRN163L)--telomerase-based cancer therapy. Recent results in cancer research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer, 184, pp. 221-234. Berlin: Springer 10.1007/978-3-642-01222-8_16


Wampfler, Julian; Tschan, Mario P; Shan, Deborah; Laemmle, Alexander; Leibundgut, Elisabeth O; Baerlocher, Gabriela M; Stroka, Deborah; Fey, Martin F; Britschgi, Christian (2009). SIRT1 is downregulated during neutrophil differentiation of acute promyelocytic leukaemia cells. British journal of haematology, 146(3), pp. 337-41. Oxford: Wiley-Blackwell 10.1111/j.1365-2141.2009.07749.x

Baerlocher, Gabriela M; Rovó, Alicia; Müller, Astrid; Matthey, Sybille; Stern, Martin; Halter, Jörg; Heim, Dominik; Rischewski, Johannes; Gratwohl, Alois; Tichelli, André (2009). Cellular senescence of white blood cells in very long-term survivors after allogeneic hematopoietic stem cell transplantation: the role of chronic graft-versus-host disease and female donor sex. Blood, 114(1), pp. 219-22. Washington, D.C.: American Society of Hematology 10.1182/blood-2009-03-209833


Röth, Alexander; de Beer, Dirk; Nückel, Holger; Sellmann, Ludger; Dührsen, Ulrich; Dürig, Jan; Baerlocher, Gabriela M (2008). Significantly shorter telomeres in T-cells of patients with ZAP-70+/CD38+ chronic lymphocytic leukaemia. British journal of haematology, 143(3), pp. 383-6. Oxford: Wiley-Blackwell 10.1111/j.1365-2141.2008.07363.x

Röth, Alexander; Baerlocher, Gabriela M (2008). Dyskeratosis congenita. British journal of haematology, 141(4), p. 412. Oxford: Wiley-Blackwell 10.1111/j.1365-2141.2008.07052.x

Savage, Sharon A; Giri, Neelam; Baerlocher, Gabriela M; Orr, Nick; Lansdorp, Peter M; Alter, Blanche P (2008). TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita. American journal of human genetics, 82(2), pp. 501-9. New York, N.Y.: Cell Press 10.1016/j.ajhg.2007.10.004

Baerlocher, GM; Röth, A (2008). Telomerbiologie im hämatologischen und onkologischen Alltag. die Enden der Chromosomen - Schlüssel zur (Un)Sterblichkeit. Forschung & Praxis - das Wissenschaftsjournal F&P(1), pp. 19-23. Neu-Isenburg: Ärzte-Zeitung-Verl.-Ges.


Baerlocher, Gabriela M; Sloand, Elaine M; Young, Neal S; Lansdorp, Peter M (2007). Telomere length in paroxysmal nocturnal hemoglobinuria correlates with clone size. Experimental hematology, 35(12), pp. 1777-81. New York, N.Y.: Elsevier 10.1016/j.exphem.2007.06.010

Alter, Blanche P; Baerlocher, Gabriela M; Savage, Sharon A; Chanock, Stephen J; Weksler, Babette B; Willner, Judith P; Peters, June A; Giri, Neelam; Lansdorp, Peter M (2007). Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita. Blood, 110(5), pp. 1439-47. Washington, D.C.: American Society of Hematology 10.1182/blood-2007-02-075598

Röth, A; Schneider, L; Himmelreich, H; Baerlocher, G M; Dührsen, U (2007). Impact of culture conditions on the proliferative lifespan of human T cells in vitro. Cytotherapy, 9(1), pp. 91-8. New York, N.Y.: Elsevier 10.1080/14653240601113197

Baerlocher, Gabriela M; Rice, Karen; Vulto, Irma; Lansdorp, Peter M (2007). Longitudinal data on telomere length in leukocytes from newborn baboons support a marked drop in stem cell turnover around 1 year of age. Aging cell, 6(1), pp. 121-3. Oxford: Blackwell Publishing 10.1111/j.1474-9726.2006.00254.x

Röth, A; Dürig, J; Himmelreich, H; Bug, S; Siebert, R; Dührsen, U; Lansdorp, P M; Baerlocher, G M (2007). Short telomeres and high telomerase activity in T-cell prolymphocytic leukemia. Leukemia, 21(12), pp. 2456-62. Basingstoke: Nature Publishing Group 10.1038/sj.leu.2404968

Ouyang, Qin; Baerlocher, Gabriela; Vulto, Irma; Lansdorp, Peter M (2007). Telomere length in human natural killer cell subsets. Annals of the New York Academy of Sciences, 1106, pp. 240-252. Boston, Mass.: Blackwell 10.1196/annals.1392.001

Wolter, I; Baerlocher, GM (2007). Chronische Myeloische Leukämie: Epidemiologie, Pathogenese, Symptomatik, Diagnostik und Therapie der CML. Onkologie(1), pp. 14-9. Basel: Karger

Gratwohl, A; Heim, D; Bargetzi, M; Baerlocher, GM; Chalandon, Y; Duchosal, M; Gregor, M; Hess, U; Oppliger Leibundgut, E; Passweg, J; Schranz, U; Dirnhofer, S (2007). Behandlung der chronischen myeloischen Leukämie 2007. Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS(7), pp. 934-940. Basel: EMH Editores Medicorum Helveticorum


Baerlocher, Gabriela M; Vulto, Irma; de Jong, Gary; Lansdorp, Peter M (2006). Flow cytometry and FISH to measure the average length of telomeres (flow FISH). Nature physics, 1(5), pp. 2365-76. Basingstoke: Nature Publishing Group 10.1038/nprot.2006.263

Savage, Sharon A; Stewart, Brian J; Weksler, Babette B; Baerlocher, Gabriela M; Lansdorp, Peter M; Chanock, Stephen J; Alter, Blanche P (2006). Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure. Blood cells, molecules, & diseases, 37(2), pp. 134-6. San Diego, Calif.: Elsevier 10.1016/j.bcmd.2006.07.001

Provide Feedback